A platelet transfusion is a procedure that delivers concentrated platelets, the tiny blood cells responsible for clotting, into your bloodstream through an IV line. It typically takes 30 to 60 minutes and is used to prevent or stop bleeding when your platelet count drops dangerously low or when your platelets aren’t functioning properly.
Platelets work by rushing to the site of a blood vessel injury, sticking to the damaged wall, and linking together to form a plug that stops bleeding. When you don’t have enough of them, even minor injuries can bleed excessively, and in severe cases, spontaneous bleeding can occur without any injury at all.
Why Platelet Transfusions Are Needed
The most common reason for a platelet transfusion is thrombocytopenia, the medical term for a dangerously low platelet count. This happens frequently in people being treated for blood cancers like leukemia or lymphoma, since chemotherapy suppresses the bone marrow where platelets are made. It also occurs in people with bone marrow failure, massive blood loss from trauma or surgery, and certain infections that destroy platelets faster than the body can replace them.
Transfusions serve two purposes. Therapeutic transfusions treat active bleeding that’s already happening. Prophylactic (preventive) transfusions are given before bleeding starts, typically when blood tests show platelet counts have dropped to levels where spontaneous bleeding becomes a real risk. Many patients undergoing chemotherapy receive repeated prophylactic transfusions over the course of their treatment.
Platelet Count Thresholds That Trigger a Transfusion
A healthy adult typically has between 150,000 and 400,000 platelets per microliter of blood. Transfusion decisions are based on how far that number has fallen and what the patient is facing.
- Below 10,000 per microliter: Prophylactic transfusion is generally recommended even without active bleeding, because the risk of spontaneous hemorrhage becomes significant at this level.
- Below 50,000 per microliter: Transfusion is typically considered before surgery or invasive procedures. For patients at higher risk of bleeding, the target may be raised to 50,000 to 75,000.
- Below 100,000 per microliter: This higher threshold applies to surgery on critical sites like the brain or the back of the eye, where even small amounts of bleeding can cause serious damage.
These thresholds aren’t rigid rules. Doctors weigh the cause of the low count, whether it’s still dropping, and whether other clotting problems exist alongside it.
Two Types of Platelet Products
Platelets come from two sources, and you may hear your care team refer to them differently.
Pooled platelets are collected from multiple whole blood donations. Each donation yields a small number of platelets, so units from four to six donors are combined into a single dose. Apheresis platelets come from a single donor who is connected to a machine that draws blood, separates out the platelets, and returns the rest. One apheresis collection provides roughly the same dose as a pooled product but exposes you to only one donor instead of several.
Apheresis platelets tend to produce a slightly better rise in platelet count at both one hour and 24 hours after transfusion. They also reduce your exposure to multiple donors, which can matter for patients who need many transfusions over time, since repeated exposure to different donors increases the chance of developing antibodies that make future transfusions less effective.
What Happens During the Procedure
Before the transfusion starts, a nurse or technician records your vital signs: temperature, blood pressure, pulse, and breathing rate. An IV line is placed, usually in your arm, and the bag of platelet concentrate is connected through a standard blood transfusion set that includes a filter to catch any small clots or debris.
The infusion itself generally runs over 30 to 60 minutes. In urgent situations where bleeding needs to be controlled quickly, it can be given faster. For patients at risk of fluid overload, such as those with heart failure, the flow rate is slowed down. Throughout the transfusion, your vitals are checked roughly every 15 minutes to catch any signs of a reaction early.
Most people feel nothing unusual during the transfusion itself. It’s similar to receiving any other IV fluid. You’ll be sitting or lying in a bed or reclining chair, and you’re generally free to read, watch something, or rest.
How Well It Works
A single unit of platelet concentrate typically raises the platelet count by 5,000 to 10,000 per microliter in an average-sized adult. A standard adult dose contains multiple units (or one apheresis collection), so you can expect a total increase of roughly 30,000 to 60,000 per microliter from a single transfusion session.
A blood test is usually drawn about an hour after the transfusion, and sometimes again at 24 hours, to confirm the platelets are circulating as expected. If the count doesn’t rise as much as anticipated, it may signal that your body is destroying the new platelets, which can happen if you’ve developed antibodies from previous transfusions or have an underlying condition consuming them rapidly.
Possible Side Effects and Risks
The most common reaction is a mild fever, sometimes accompanied by chills. This is a febrile reaction triggered by your immune system responding to proteins in the donated product. It’s uncomfortable but not dangerous and usually resolves on its own or with a fever-reducing medication.
Allergic reactions, ranging from mild hives and itching to more serious symptoms like difficulty breathing, can also occur. Mild reactions are fairly common and managed by pausing the transfusion temporarily. Severe allergic reactions are rare.
A more serious but uncommon risk is transfusion-related acute lung injury, which causes sudden breathing difficulty within hours of the transfusion. Bacterial contamination of the platelet product is another concern, and it’s the primary reason platelet units have a short shelf life. Platelets are stored at room temperature (around 20 to 24°C) with constant gentle agitation, which is ideal for preserving their function but also creates an environment where bacteria can grow. Because of this, platelet units expire after just five days, making them one of the most perishable blood products.
When Platelet Transfusions Are Avoided
Not every low platelet count calls for a transfusion. In certain conditions, giving platelets can actually make things worse. In thrombotic thrombocytopenic purpura (TTP), a rare disorder where abnormal clotting uses up platelets throughout the body, adding more platelets has been linked to potentially worsening the dangerous clot formation. Platelet transfusions in TTP are reserved for life-threatening bleeding only.
A similar caution applies to heparin-induced thrombocytopenia (HIT), a condition where the blood thinner heparin triggers an immune reaction that destroys platelets while simultaneously promoting clots. Prophylactic platelet transfusions are generally avoided in HIT patients because they may fuel further clotting rather than reduce bleeding risk. In immune thrombocytopenia (ITP), where the immune system destroys platelets, transfusions are typically reserved for catastrophic hemorrhage or situations requiring surgery, since transfused platelets are often destroyed as quickly as the patient’s own.
Chronic bone marrow failure is another situation where routine prophylactic transfusions are not standard. Because these patients need long-term management, the risks of repeated transfusions, including antibody development and iron overload, generally outweigh the benefits unless bleeding is active.